A phase II randomized, observer-blind, active-controlled study to evaluate the immunogenicity and the safety of BioNet recombinant pertussis vaccines with different doses of genetically detoxified pertussis toxin (PTgen) when administered to healthy pregnant women

Safety and Antibody Responses in Adults and Elderly after Immunization with a Recombinant Pertussis Booster Dose